Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arbor Preservative Systems is a medical technology company focused on improving the viability of donor organs for transplantation. The company develops advanced preservation solutions designed to extend the time organs can remain outside the body while maintaining physiological function. Their primary technology aims to reduce ischemia-reperfusion injury and improve outcomes for transplant recipients. The company's work is rooted in research from the University of Michigan, particularly in the field of extracorporeal life support and organ perfusion. Arbor's solutions are designed to optimize the metabolic environment of the donor organ during transport and storage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arbor Preservative Systems.